105 related articles for article (PubMed ID: 1644930)
21. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
22. Absence of germline p53 mutations in familial lymphoma.
Weintraub M; Lin AY; Franklin J; Tucker MA; Magrath IT; Bhatia KG
Oncogene; 1996 Feb; 12(3):687-91. PubMed ID: 8637726
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
24. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.
Horio Y; Suzuki H; Ueda R; Koshikawa T; Sugiura T; Ariyoshi Y; Shimokata K; Takahashi T; Takahashi T
Oncogene; 1994 Apr; 9(4):1231-5. PubMed ID: 8134126
[TBL] [Abstract][Full Text] [Related]
25. Cancer risks from germ line tumor suppressor gene mutations.
Frebourg T; Malkin D; Friend S
Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
[TBL] [Abstract][Full Text] [Related]
26. p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer.
Leonard DG; Travis LB; Addya K; Dores GM; Holowaty EJ; Bergfeldt K; Malkin D; Kohler BA; Lynch CF; Wiklund T; Stovall M; Hall P; Pukkala E; Slater DJ; Felix CA
Clin Cancer Res; 2002 May; 8(5):973-85. PubMed ID: 12006509
[TBL] [Abstract][Full Text] [Related]
27. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
[TBL] [Abstract][Full Text] [Related]
28. Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias.
Pignon JM; Vinatier I; Fanen P; Jonveaux P; Tournilhac O; Imbert M; Rochant H; Goossens M
Hum Mutat; 1994; 3(2):126-32. PubMed ID: 8199593
[TBL] [Abstract][Full Text] [Related]
29. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
Pötzsch C; Voigtländer T; Lübbert M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the p53 gene do not occur in testis cancer.
Peng HQ; Hogg D; Malkin D; Bailey D; Gallie BL; Bulbul M; Jewett M; Buchanan J; Goss PE
Cancer Res; 1993 Aug; 53(15):3574-8. PubMed ID: 8339263
[TBL] [Abstract][Full Text] [Related]
31. Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
[TBL] [Abstract][Full Text] [Related]
32. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.
Hensel CH; Xiang RH; Sakaguchi AY; Naylor SL
Oncogene; 1991 Jun; 6(6):1067-71. PubMed ID: 1648702
[TBL] [Abstract][Full Text] [Related]
33. Absence of p53 gene mutations in primary neuroblastomas.
Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P
Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661
[TBL] [Abstract][Full Text] [Related]
34. Screening for germline p53 mutations in pediatric and adult patients of high-risk groups in Poland.
Fiszer-Maliszewska L; Czernik J; Sawicz-Birkowska K; Perek D; Kozera M; Wojciechowska B; Kazanowska B; Hudziec P; Kilar E
Arch Immunol Ther Exp (Warsz); 2000; 48(4):309-15. PubMed ID: 11059649
[TBL] [Abstract][Full Text] [Related]
35. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
36. The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
Felix CA; Hosler MR; Provisor D; Salhany K; Sexsmith EA; Slater DJ; Cheung NK; Winick NJ; Strauss EA; Heyn R; Lange BJ; Malkin D
Blood; 1996 May; 87(10):4376-81. PubMed ID: 8639798
[TBL] [Abstract][Full Text] [Related]
37. Familial and metachronous malignant lymphoma: absence of constitutional p53 mutations.
Pötzsch C; Schaefer HE; Lübbert M
Am J Hematol; 1999 Nov; 62(3):144-9. PubMed ID: 10539880
[TBL] [Abstract][Full Text] [Related]
38. Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of France.
Preudhomme C; Fenaux P; Peyrat JP; Fournier J; Bonneterre J; Vennin P
Eur J Cancer; 1993; 29A(10):1476-8. PubMed ID: 8398277
[TBL] [Abstract][Full Text] [Related]
39. Germline p53 mutation at codon 133 in a cancer-prone family.
Saeki Y; Tamura K; Yamamoto Y; Hatada T; Furuyama J; Utsunomiya J
J Mol Med (Berl); 1997 Jan; 75(1):50-6. PubMed ID: 9020384
[TBL] [Abstract][Full Text] [Related]
40. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase.
Hsiao MH; Yu AL; Yeargin J; Ku D; Haas M
Blood; 1994 May; 83(10):2922-30. PubMed ID: 8180387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]